Rhythm Pharmaceuticals (RYTM) PT Raised to $50 at Stifel
Tweet
Share
E-mailGet Alerts RYTM Hot Sheet
Price: $108.92 -5.88%
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Stifel analyst Dae Gon Ha raised the price target on Rhythm Pharmaceuticals (NASDAQ: RYTM) to $50.00 (from $44.00) while maintaining a Buy rating.
You May Also Be Interested In
- Nutanix (NTNX) PT Raised to $80 at Oppenheimer Into EPS
- Hims and Hers (HIMS) PT Lowered to $35 at Barclays
- SentinelOne Inc (S) PT Raised to $26 at Cantor Fitzgerald Following Strong Q2 Checks
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
